Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix
Earlier from Jiangsu Lianhuan Pharmaceutical
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Obtaining a Drug Registration Certificate from the Republic of Ghana
- Announcement on Increasing Capital to Wholly-owned Subsidiary
- Announcement on Progress in Asset Purchase by Wholly-owned Subsidiary and Related Party Transactions
- Announcement on Resolutions of the 21st Extraordinary Meeting of the 9th Board of Directors
Later from Jiangsu Lianhuan Pharmaceutical
- Announcement on the Execution of Daily Related Party Transactions in 2025 and the Estimated Daily Related Party Transactions in 2026
- Announcement on the Signing of the "Project Entry Contract for the Science and Innovation Center" by with Yangzhou High-tech Industrial Development Zone
- Announcement on Unblinding Results of the Phase III Clinical Trial of Company's Class 1 New Drug LH-1801 Tablets Combined with Metformin
- Announcement on the Holding Subsidiary Obtaining the Approval Notice for Drug Supplementary Application
- Investor Relations Activity Record Form
Follow Jiangsu Lianhuan Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Lianhuan Pharmaceutical